BENJAMIN SEXTON: Open Payments
NPI 1982905444 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$479 in 27 payments from 13 companies in 2025. Trend: 2023 $511 · 2024 $731 · 2025 $479
Food & beverage: $479
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $63 |
| Corium, LLC | 2 | $56 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| Novo Nordisk Inc | 3 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $44 |
| ABBVIE INC. | 2 | $44 |
| Abbott Laboratories | 2 | $40 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $34 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: PREVNAR 20, Azstarys, JARDIANCE, UBRELVY, FREESTYLE LIBRE 3, TRELEGY ELLIPTA, Jornay PM, MOUNJARO.
Industry payments across AR — which companies pay providers there.
